Abacus Planning Group, Inc. Novo Nordisk A S Transaction History

Abacus Planning Group, Inc.

  • $545 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
SELL
$122.71 - $146.91 $8,098 - $9,696
-66 Reduced 3.98%
1,593 $227,000
Q1 2024

Apr 11, 2024
SELL
$102.11 - $135.92 $68,107 - $90,658
-667 Reduced 28.68%
1,659 $213,000
Q4 2023

Jan 19, 2024
SELL
$87.78 - $105.45 $14,747 - $17,715
-168 Reduced 6.74%
2,326 $240,000
Q3 2023

Oct 11, 2023
BUY
$90.94 - $199.54 $226,804 - $497,652
2,494 New
2,494 $226,000
Q1 2023

Apr 17, 2023
BUY
$132.34 - $159.14 $256,474 - $308,413
1,938 New
1,938 $308,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Abacus Planning Group, Inc. Portfolio

Follow Abacus Planning Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abacus Planning Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email